Letrozole - Fecinole DOSA EN.pdf

Name of the product: FECINOLE

Active ingredient: Letrozole 2.5 mg

Dosage form: film-coated tablets

Dispensing requirements: Rx only

Argentine Industry

Composition:

Each film-coated tablet contains letrozole 2.5 mg, lactose monohydrate, microcrystalline cellulose, silicium dioxide, sodium starch glycolate, corn starch, magnesium stearate, ferric oxide, and Opadry.

Indications:

FECINOLE is indicated for the treatment of the advanced breast cancer in women undergoing natural or artificially induced postmenopause after the disease progression or recurrence following antiestrogen therapy.

Therapeutic action:

Antiestrogenic.

Storage:

Keep at temperature between 15º and 30º C, in the marketed packing.

Marketed presentations:

Packs containing 30 film-coated tablets.

Medicinal speciality authorised by the Ministry of Health.

Certificate Nº 48950

Laboratorio DOSA S.A.

Girardot 1369, (C1427AKC) Buenos Aires, Argentine

Pharmaceutical Director: María C. Terzo, Pharmacist